Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
17.47
-1.88 (-9.72%)
Sep 23, 2026, 12:39 PM EDT - Market open
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $3.83 billion as of September 23, 2026. Its market cap has increased by 389.10% in one year.
Market Cap
3.83B
Enterprise Value
2.95B
1-Year Change
389.10%
Ranking
Category
Stock Price
$17.47
ChartMarket Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has increased from $3.03B to $3.83B, an increase of 26.15%. That is a compound annual growth rate of 3.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 3.83B | 161.09% |
| Dec 31, 2025 | 1.47B | 112.63% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 4.83B |
| Iovance Biotherapeutics | 4.82B |
| Viking Therapeutics | 4.77B |
| Parabilis Medicines | 4.72B |
| ACADIA Pharmaceuticals | 4.55B |
| Tango Therapeutics | 4.30B |
| Celcuity | 4.12B |
| AbCellera Biologics | 4.10B |